Assessing the WAVE Extra Soft Coil in Intracranial Aneurysms and Comparing Imaging Modalities
(SURF Trial)
Recruiting in Palo Alto (17 mi)
+55 other locations
CM
Overseen byClemens M Schirmer, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Penumbra Inc.
No Placebo Group
Trial Summary
What is the purpose of this trial?
The objective of this study is to demonstrate the safety and efficacy of the Penumbra SMART COIL® System, including the WAVE™ Extra Soft Coils (WAVE) as a fill and finish coil, in the treatment of intracranial aneurysms. Imaging will be analyzed by an independent core lab to assess aneurysm occlusion rates and perform a comparative analysis between imaging modalities.
Research Team
CM
Clemens M Schirmer, MD
Principal Investigator
Geisinger Clinic
Eligibility Criteria
Inclusion Criteria
Patient age ≥ 18 years
Patient having embolization of intracranial aneurysms
WAVE Extra Soft Coil is final finishing coil
See 2 more
Treatment Details
Interventions
- WAVE Extra Soft Coil (Coil)
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Single ArmExperimental Treatment1 Intervention
Single Arm - Patients with intracranial aneurysms treated with WAVE, as part of the Penumbra SMART COIL System
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
RIAEnglewood, CO
Erlanger Baroness HospitalChattanooga, TN
Indiana University Health Methodist HospitalIndianapolis, IN
Toronto WesternToronto, Canada
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Penumbra Inc.
Lead Sponsor
Trials
38
Recruited
10,800+